Capital Fund Management (CFM)’s Masco MAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-15,900
Closed -$1.12M 2537
2025
Q3
$1.12M Sell
15,900
-7,600
-32% -$535K ﹤0.01% 2055
2025
Q2
$1.51M Buy
+23,500
New +$1.48M ﹤0.01% 1821
2025
Q1
Sell
-14,000
Closed -$1.02M 2201
2024
Q4
$1.02M Sell
14,000
-4,900
-26% -$392K ﹤0.01% 1754
2024
Q3
$1.59M Buy
18,900
+8,600
+83% +$652K ﹤0.01% 1533
2024
Q2
$687K Buy
+10,300
New +$726K ﹤0.01% 1695
2021
Q4
Sell
-20,000
Closed -$1.11M 1746
2021
Q3
$1.11M Buy
20,000
+1,800
+10% +$107K 0.01% 1157
2021
Q2
$1.07M Buy
+18,200
New +$1.12M 0.01% 1140
2021
Q1
Sell
-26,300
Closed -$1.44M 1478
2020
Q4
$1.44M Sell
26,300
-4,700
-15% -$259K 0.01% 884
2020
Q3
$1.71M Buy
+31,000
New +$1.74M 0.02% 685
2019
Q2
Sell
-5,900
Closed -$232K 1793
2019
Q1
$232K Sell
5,900
-20,300
-77% -$724K ﹤0.01% 1534
2018
Q4
$766K Buy
+26,200
New +$814K 0.01% 1201
2014
Q1
Sell
-42,334
Closed -$847K 1857
2013
Q4
$847K Sell
42,334
-71,921
-63% -$1.34M 0.01% 1051
2013
Q3
$2.14M Buy
+114,255
New +$2.03M 0.03% 618

Other funds holding MAS

Capital Fund Management (CFM)'s MAS Position: Q3 2025 in Review

Capital Fund Management (CFM) sold out of Masco (MAS) in Q3 2025, closing a stake of 90,854 shares — an estimated $6.39M sold.

Capital Fund Management (CFM) first reported a position in MAS in Q3 2013 and held it in 31 quarters. The position peaked at $32.9M in Q2 2016. 873 funds tracked by Wall St. Rank hold MAS as of Q3 2025.

  • Capital Fund Management (CFM) reported no remaining Masco position as of Q3 2025 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 90,854 Masco shares in Q3 2025, an estimated $6.39M.
  • Capital Fund Management (CFM) first reported a position in Masco in Q3 2013 and held it in 31 quarters.
  • Capital Fund Management (CFM)'s Masco position peaked at $32.9M in Q2 2016.
  • 873 funds tracked by Wall St. Rank held Masco as of Q3 2025.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2025, filed 13 Nov 2025.